Latest Asx Listings News

Dragon Mountain Gold Limited reports promising drilling results at its Avalon Project and prepares for further exploration at Cawse, supported by a successful $670,000 capital raise and strategic board appointment.

Vintage Energy has launched a $2.1 million entitlement offer to fund a targeted production uplift program at its Odin and Vali gas fields, aiming to significantly increase gas output and cash flow in the near term.

Vitrafy Life Sciences reports strong Q2 FY2025 progress, marked by a successful $35 million IPO, promising validation results in animal and human health, and strategic expansion into North America.

Alma Metals reports strong drilling results at its Briggs Copper Project, revealing higher-grade copper zones near surface and a promising new mineralisation discovery at the Southern Porphyry Target. The company advances its resource update and mining studies with a solid cash position.

Mount Ridley Mines has completed a 1-for-10 capital consolidation and refreshed its board with experienced new directors, positioning itself for strategic growth amid ongoing portfolio evaluations.

Newfield Resources clarifies its $10 million loan facility status, postpones key sampling work, and updates on ongoing dispute with Octea Limited, signaling cautious navigation through financial and operational challenges.

Tempest Minerals reports maiden drilling success at its Remorse target, revealing significant high-grade magnetite and base metal anomalies with an initial exploration target of up to 110 million tonnes at 30-32% iron.

Betashares Capital Ltd has announced estimated distribution amounts for its suite of ASX-listed funds for the January 2025 period, providing investors with crucial income expectations ahead of final figures.

MFF Capital Investments Limited has reported a striking net profit after tax of $381.5 million for the half year ended December 31, 2024, more than doubling last year’s result. The company also announced an increased fully franked interim dividend of 8 cents per share, underscoring its robust financial position and growth trajectory.

ASF Group Limited reported a $1.58 million cash balance for the December 2024 quarter, highlighting ongoing investments and a director retirement that could influence its strategic direction.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.

Lake Resources NL reported a robust cash position of AUD 22.56 million for Q4 2024, bolstered by a $13.6 million sale of non-core assets and steady progress on the Kachi lithium project’s environmental and engineering milestones.